ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,222.68
0.16%
US Tech 100
17,650.00
0.05%
다우존스 지수
39,512.84
0.32%
Bitcoin
61,121.01
0.53%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Dyne Therapeutics Inc (DYN)

  7. Dyne Therapeutics Inc (DYN) 뉴스

DYN Dyne Therapeutics Inc

26.00
0.05 (0.19%)
11 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Dyne Therapeutics Inc DYN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.05 0.19% 26.00 13:00:08
개장가 저가 고가 종가 전일 종가
25.96 25.07 26.48 26.00 25.95
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
03/05/202405:10GLOBEDyne Therapeutics Reports First Quarter 2024 Financial..
28/03/202405:05GLOBEDyne Therapeutics Reports Inducement Grant Under Nasdaq..
27/03/202421:30GLOBEDyne Therapeutics to Present at the Cantor Virtual Muscular..
25/03/202420:30GLOBEDyne Therapeutics Announces CEO Transition
13/03/202420:30GLOBEDyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
12/03/202406:36EDGAR2Form 144 - Report of proposed sale of securities
12/03/202406:35EDGAR2Form 144 - Report of proposed sale of securities
12/03/202406:35EDGAR2Form 144 - Report of proposed sale of securities
09/03/202406:53EDGAR2Form 144 - Report of proposed sale of securities
08/03/202410:19EDGAR2Form 144 - Report of proposed sale of securities
08/03/202410:18EDGAR2Form 144 - Report of proposed sale of securities
08/03/202410:16EDGAR2Form 144 - Report of proposed sale of securities
05/03/202422:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
05/03/202421:41EDGAR2Form 8-K - Current report
05/03/202421:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/03/202421:35EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/03/202421:30GLOBEDyne Therapeutics Reports Fourth Quarter and Full Year 2023..
02/03/202411:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202411:33EDGAR2Form 144 - Report of proposed sale of securities
02/03/202407:08EDGAR2Form 144 - Report of proposed sale of securities
01/03/202409:49EDGAR2Form 144 - Report of proposed sale of securities
24/02/202407:23EDGAR2Form 144 - Report of proposed sale of securities
15/02/202406:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:15GLOBEDyne Therapeutics Announces Upcoming Presentations on..
14/02/202422:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202407:40EDGAR2Form 144 - Report of proposed sale of securities
01/02/202421:30GLOBEDyne Therapeutics to Present at February Investor..
27/01/202409:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202409:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/01/202409:46EDGAR2Form 144 - Report of proposed sale of securities
12/01/202406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202406:05GLOBEDyne Therapeutics Announces Closing of Public Offering of..
06/01/202406:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/01/202422:02EDGAR2Form 8-K - Current report
05/01/202421:30GLOBEDyne Therapeutics to Present at 42nd Annual J.P. Morgan..
05/01/202412:46GLOBEDyne Therapeutics Announces Pricing of $300 Million Public..
05/01/202411:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202411:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202411:45EDGAR2Form 144 - Report of proposed sale of securities
05/01/202411:45EDGAR2Form 144 - Report of proposed sale of securities
05/01/202411:19EDGAR2Form S-3MEF - Registration adding securities to prior Form..
05/01/202407:12EDGAR2Form 8-K - Current report
04/01/202410:14EDGAR2Form 144 - Report of proposed sale of securities
04/01/202410:12EDGAR2Form 144 - Report of proposed sale of securities
04/01/202406:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/01/202406:25GLOBEDyne Therapeutics Announces Proposed Public Offering of..
03/01/202420:37EDGAR2Form 8-K - Current report
03/01/202420:30GLOBEDyne Therapeutics Announces Positive Initial Clinical Data..
03/01/202406:05GLOBEDyne Therapeutics to Host Virtual Event Tomorrow, January 3..
30/12/202311:03EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NASDAQ
DYN
Dyne Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유